GABPA and hepatocellular carcinoma: Our current study revealed the significant downregulation of HPN-AS1 resulted from downregulation of GABPA within HCC cells and the molecular mechanisms by which HPN-AS1 inhibits cell proliferation and promotes cell apoptosis in HCC via enhancing the degradation of eIF4A3.